WARRENDALE, Pa.—Medical device company Renal Solutions Inc. said today that the U.S. Food and Drug Administration has cleared the newly enhanced Allient Sorbent Hemodialysis System.
Renal Solutions said the new Allient System has improvements in the ease of manufacturing, service and user-friendliness. The Allient System last received FDA clearance for improvements in June 2006.
And in advance of the Allient System’s commercialization, the company also said that it is launching its SMARRT (Sorbent Management for Advanced Renal Replacement Therapy) platform and campaign in order to educate the renal community about the benefits of advanced sorbent technology.
According to Renal Solutions, the SMARRT approach uses 1.5 gallons (6 liters) of drinking water for short, standard or extended hemodialysis therapy. “The small dialysate quantity made possible by sorbent technology provides an inherent volume safety not possible with conventional hemodialysis technology,” Renal Solutions said in a press release. “At the same time, it creates a dialysate flow rate of up to 400mL/min, enabling the provision of highly effective dialysis. Advanced sorbent cartridges contain specialized sorbent compounds that regenerate fresh, high purity dialysate, eliminating the need for complex and costly water systems.”
